EXAMINING PLACENTA ACCRETA, PERCRETA, AND INCRETA IN PERIPARTUM HYSTERECTOMIES: A RETROSPECTIVE CROSS-SECTIONAL STUDY.

Abstract

Background

Abnormal placentation, encompassing placenta accreta, increta, and percreta, poses significant risks to maternal health, necessitating prompt diagnosis and management. With increasing cesarean delivery rates contributing to rising incidences of these conditions, understanding their clinical characteristics, management approaches, and outcomes in peripartum hysterectomies is crucial. The study seeks to investigate the incidence, clinical characteristics, association, and outcomes of placenta accreta, percreta, and increta in peripartum hysterectomies.

 Methods

A retrospective cross-sectional study was conducted in which 40 participants meeting inclusion criteria, such as antenatal diagnoses of abnormal placentation or relevant obstetric histories, were included. Clinical data were collected from histology requisition forms, with statistical analysis achieved using SPSS version 21.0.

 Results

The study revealed a notable incidence of abnormal placentation, with placenta accreta being the most common (62.5%). Clinical presentations varied, with antepartum hemorrhage predominating (70%). Peripartum hysterectomy emerged as the primary management strategy, yielding favorable maternal outcomes overall. Statistical analysis identified associations between previous cesarean sections and abnormal placentation incidence, highlighting the importance of risk mitigation strategies (p < 0.05).

 Conclusion

Abnormal placentation remains a significant concern in peripartum care, necessitating a multidisciplinary approach for optimal management. Early diagnosis, prompt intervention, and ongoing research are essential to improve maternal outcomes and minimize complications associated with these conditions.

 Recommendations

Healthcare providers should prioritize early and accurate diagnosis, adopt a multidisciplinary approach to management, and focus on mitigating risk factors such as previous cesarean sections. Continued research and education are essential for refining treatment strategies and improving outcomes for women affected by abnormal placentation.